Galapagos reports early clinical results for SIK inhibitor by Lucy Parsons | Jul 15, 2021 | News | 0 Novel drug candidate found to be generally safe and well-tolerated in inflammatory indications Read More
New pharma Azadyne raises £1.5m for autoimmune disease treatment by Anna Smith | Mar 28, 2019 | News | 0 The Trinity College spin-off has completed a £1.5-million funding round for its autoimmune treatments. Read More